Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 668

1.

Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth.

Inada M, Sato A, Shindo M, Yamamoto Y, Akasaki Y, Ichimura K, Tanuma SI.

Anticancer Res. 2019 Dec;39(12):6743-6750. doi: 10.21873/anticanres.13889.

PMID:
31810939
2.

Correction: Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.

Otsuka M, Monzen H, Matsumoto K, Tamura M, Inada M, Kadoya N, Nishimura Y.

PLoS One. 2019 Nov 27;14(11):e0225965. doi: 10.1371/journal.pone.0225965. eCollection 2019.

3.

Chuukese community experiences of racial discrimination and other barriers to healthcare: Perspectives from community members and providers.

Inada MK, Braun KL, Mwarike P, Cassel K, Compton R, Yamada S, Sentell T.

Soc Med (Soc Med Publ Group). 2019 Jan-Apr;12(1):3-13. No abstract available.

4.

Archaeal Glycolipid S-TGA-1 Is Crucial for Trimer Formation and Photocycle Activity of Bacteriorhodopsin.

Inada M, Kinoshita M, Matsumori N.

ACS Chem Biol. 2019 Nov 4. doi: 10.1021/acschembio.9b00756. [Epub ahead of print]

PMID:
31647217
5.

Effect of piceatannol-rich passion fruit seed extract on human glyoxalase I-mediated cancer cell growth.

Yamamoto T, Sato A, Takai Y, Yoshimori A, Umehara M, Ogino Y, Inada M, Shimada N, Nishida A, Ichida R, Takasawa R, Maruki-Uchida H, Mori S, Sai M, Morita M, Tanuma SI.

Biochem Biophys Rep. 2019 Aug 30;20:100684. doi: 10.1016/j.bbrep.2019.100684. eCollection 2019 Dec.

6.

Pilinahā: An Indigenous Framework for Health.

Odom SK, Jackson P, Derauf D, Inada MK, Aoki AH.

Curr Dev Nutr. 2019 Feb 22;3(Suppl 2):32-38. doi: 10.1093/cdn/nzz001. eCollection 2019 Aug.

7.

Impact of nursing experience on cancellation of light sedation for mechanically ventilated patients in a setting of 1 : 2 nurse-patient ratio.

Tsuyada H, Inoue S, Tsujimoto T, Ogawa T, Inada M, Kawaguchi M.

Anaesthesiol Intensive Ther. 2019;51(3):210-217. doi: 10.5114/ait.2019.87359.

8.

Ultrasensitive ELISA Developed for Diagnosis.

Iha K, Inada M, Kawada N, Nakaishi K, Watabe S, Tan YH, Shen C, Ke LY, Yoshimura T, Ito E.

Diagnostics (Basel). 2019 Jul 18;9(3). pii: E78. doi: 10.3390/diagnostics9030078. Review.

9.

Quantitative Measurements of Intercellular Adhesion Strengths between Cancer Cells with Different Malignancies Using Atomic Force Microscopy.

Kim H, Ishibashi K, Matsuo K, Kira A, Okada T, Watanabe K, Inada M, Nakamura C.

Anal Chem. 2019 Aug 20;91(16):10557-10563. doi: 10.1021/acs.analchem.9b01569. Epub 2019 Aug 1.

PMID:
31322341
10.

Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers.

Nishida T, Matsubara T, Yakushijin T, Inada M.

Hepatol Int. 2019 Jul;13(4):407-415. doi: 10.1007/s12072-019-09966-z. Epub 2019 Jul 9. Review.

PMID:
31290069
11.

A Triple-Drug Blister-Packaged Drug with Vonoprazan Improves First-Line Eradication of Helicobacter pylori in Elderly Patients: A Retrospective Propensity Score-Matched Cohort Study.

Nishida T, Tsujii Y, Okamoto A, Tomita R, Higaki Y, Osugi N, Sugimoto A, Takahashi K, Mukai K, Nakamatsu D, Matsubara T, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M.

Digestion. 2019 Jul 9:1-7. doi: 10.1159/000501608. [Epub ahead of print]

PMID:
31288235
12.

Pedals and Pedagogy: Cycles of Hope and Health.

Faller EK, Jean-Pierre G, Inada M, Acido JM.

Hawaii J Med Public Health. 2019 Jun;78(6 Suppl 1):61-64.

13.

Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy.

Yamakado S, Cho H, Inada M, Morikawa M, Jiang YH, Saito K, Nakaishi K, Watabe S, Takagi H, Kaneda M, Nakatsuma A, Ninomiya M, Imachi H, Arai T, Yoshimoto T, Murao K, Chang JH, Chen SM, Shih YC, Zeng MJ, Ke LY, Chen CH, Yoshimura T, Miura T, Ito E.

BMJ Open Diabetes Res Care. 2019 May 30;7(1):e000661. doi: 10.1136/bmjdrc-2019-000661. eCollection 2019.

14.

Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.

Inada M, Nishimura Y, Ishikawa K, Nakamatsu K, Wada Y, Uehara T, Fukuda K, Anami S, Doi H, Kanamori S.

Esophagus. 2019 Oct;16(4):371-376. doi: 10.1007/s10388-019-00675-y. Epub 2019 May 20.

PMID:
31111308
15.

Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.

Inada M, Shindo M, Kobayashi K, Sato A, Yamamoto Y, Akasaki Y, Ichimura K, Tanuma SI.

PLoS One. 2019 May 17;14(5):e0216358. doi: 10.1371/journal.pone.0216358. eCollection 2019.

16.

Hypergravity and microgravity exhibited reversal effects on the bone and muscle mass in mice.

Tominari T, Ichimaru R, Taniguchi K, Yumoto A, Shirakawa M, Matsumoto C, Watanabe K, Hirata M, Itoh Y, Shiba D, Miyaura C, Inada M.

Sci Rep. 2019 Apr 29;9(1):6614. doi: 10.1038/s41598-019-42829-z.

17.

Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors.

Nishida T, Sugimoto A, Tomita R, Higaki Y, Osugi N, Takahashi K, Mukai K, Matsubara T, Nakamatsu D, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M.

World J Gastrointest Oncol. 2019 Jan 15;11(1):28-38. doi: 10.4251/wjgo.v11.i1.28.

18.

A concise method for quantitative analysis of interactions between lipids and membrane proteins.

Inada M, Kinoshita M, Sumino A, Oiki S, Matsumori N.

Anal Chim Acta. 2019 Jun 20;1059:103-112. doi: 10.1016/j.aca.2019.01.042. Epub 2019 Feb 1.

PMID:
30876624
19.

Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.

Tamada K, Nakajima S, Ogawa N, Inada M, Shibasaki H, Sato A, Takasawa R, Yoshimori A, Suzuki Y, Watanabe N, Oyama T, Abe H, Inoue S, Abe T, Yokomizo T, Tanuma S.

Biochem Biophys Res Commun. 2019 Apr 9;511(3):665-670. doi: 10.1016/j.bbrc.2019.01.136. Epub 2019 Feb 27.

PMID:
30826057
20.

Postoperative intensive care unit admission does not affect outcomes in elective surgical patients with severe comorbidity.

Ogawa T, Inoue S, Inada M, Kawaguchi M.

Med Intensiva. 2019 Feb 21. pii: S0210-5691(19)30030-0. doi: 10.1016/j.medin.2019.01.003. [Epub ahead of print] English, Spanish.

PMID:
30799043
21.

Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity.

Hirata N, Ichimaru R, Tominari T, Matsumoto C, Watanabe K, Taniguchi K, Hirata M, Ma S, Suzuki K, Grundler FMW, Miyaura C, Inada M.

Nutrients. 2019 Feb 10;11(2). pii: E368. doi: 10.3390/nu11020368.

22.

Multiplex Real-Time Loop-Mediated Isothermal Amplification Using an Electrochemical DNA Chip Consisting of a Single Liquid-Flow Channel.

Hashimoto K, Inada M, Ito K.

Anal Chem. 2019 Mar 5;91(5):3227-3232. doi: 10.1021/acs.analchem.8b05284. Epub 2019 Feb 19.

PMID:
30734558
23.

Prediction of survival benefit when deciding between chemotherapy and best supportive therapy in elderly patients with advanced gastric cancer: A retrospective cohort study.

Sugimoto A, Nishida T, Osugi N, Takahashi K, Mukai K, Nakamatsu D, Matsubara T, Hayashi S, Yamamoto M, Nakajima S, Fukui K, Inada M.

Mol Clin Oncol. 2019 Jan;10(1):83-91. doi: 10.3892/mco.2018.1772. Epub 2018 Nov 19.

24.

Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.

Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):e116-e136. doi: 10.1164/rccm.201810-1895ST.

25.

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response.

Yamada R, Hiramatsu N, Oze T, Urabe A, Tahata Y, Morishita N, Kodama T, Hikita H, Sakamori R, Yakushijin T, Yamada A, Hagiwara H, Mita E, Oshita M, Itoh T, Fukui H, Inui Y, Hijioka T, Inada M, Katayama K, Tamura S, Inoue A, Imai Y, Tatsumi T, Hamasaki T, Hayashi N, Takehara T.

Hepatol Res. 2019 May;49(5):570-578. doi: 10.1111/hepr.13310. Epub 2019 Feb 6.

PMID:
30623521
26.

Sodium titanium oxide bronze nanoparticles synthesized via concurrent reduction and Na+-doping into TiO2(B).

Hasegawa G, Tanaka M, Vequizo JJM, Yamakata A, Hojo H, Kobayashi M, Kakihana M, Inada M, Akamatsu H, Hayashi K.

Nanoscale. 2019 Jan 17;11(3):1442-1450. doi: 10.1039/c8nr08372j.

PMID:
30608497
27.

Neutrophil-to-Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer.

Doi H, Nakamatsu K, Anami S, Fukuda K, Inada M, Tatebe H, Ishikawa K, Kanamori S, Monzen H, Nishimura Y.

In Vivo. 2019 Jan-Feb;33(1):195-201. doi: 10.21873/invivo.11459.

28.

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy.

Anami S, Doi H, Nakamatsu K, Uehara T, Wada Y, Fukuda K, Inada M, Ishikawa K, Kanamori S, Nishimura Y.

J Radiat Res. 2019 Mar 1;60(2):257-263. doi: 10.1093/jrr/rry107.

29.

Endoscopic findings of inverted pyloric gland adenoma resected by endoscopic submucosal dissection.

Yamamoto M, Nishida T, Nakamatsu D, Adachi S, Inada M.

J Gastrointestin Liver Dis. 2018 Dec;27(4):361. doi: 10.15403/jgld.2014.1121.274.end. No abstract available.

30.

Correction: Radiation exposure dose and influencing factors during endoscopic retrograde cholangiopancreatography.

Hayashi S, Nishida T, Matsubara T, Osugi N, Sugimoto A, Takahashi K, Mukai K, Nakamatsu D, Yamamoto M, Fukui K, Inada M.

PLoS One. 2018 Dec 20;13(12):e0209877. doi: 10.1371/journal.pone.0209877. eCollection 2018.

31.

Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.

Asano R, Asai-Sato M, Matsukuma S, Mizushima T, Taguri M, Yoshihara M, Inada M, Fukui A, Suzuki Y, Miyagi Y, Miyagi E.

Fertil Steril. 2019 Jan;111(1):178-185. doi: 10.1016/j.fertnstert.2018.09.014. Epub 2018 Dec 13.

PMID:
30554729
32.

Radiation exposure dose and influencing factors during endoscopic retrograde cholangiopancreatography.

Hayashi S, Nishida T, Matsubara T, Osugi N, Sugimoto A, Takahashi K, Mukai K, Nakamatsu D, Yamamoto M, Fukui K, Inada M.

PLoS One. 2018 Nov 19;13(11):e0207539. doi: 10.1371/journal.pone.0207539. eCollection 2018. Erratum in: PLoS One. 2018 Dec 20;13(12):e0209877.

33.

Alveolar Echinococcosis Mimicking a Hepatic Neoplasm with Lymph Node Metastasis: A Case Report.

Amano T, Hayashi S, Nishida T, Matsubara T, Takahashi K, Nakamatsu D, Tomimaru Y, Yamamoto M, Nakajima S, Fukui K, Tamura H, Adachi S, Dono K, Inada M.

Case Rep Gastroenterol. 2018 Oct 2;12(3):587-596. doi: 10.1159/000492461. eCollection 2018 Sep-Dec.

34.

Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.

Otsuka M, Monzen H, Matsumoto K, Tamura M, Inada M, Kadoya N, Nishimura Y.

PLoS One. 2018 Oct 3;13(10):e0204721. doi: 10.1371/journal.pone.0204721. eCollection 2018. Erratum in: PLoS One. 2019 Nov 27;14(11):e0225965.

35.

Protective effects of dexamethasone on hypoxia-induced retinal edema in a mouse model.

Inada M, Taguchi M, Harimoto K, Karasawa Y, Takeuchi M, Ito M.

Exp Eye Res. 2019 Jan;178:82-90. doi: 10.1016/j.exer.2018.09.014. Epub 2018 Sep 26.

PMID:
30267655
36.

Distinct Clinical Factors in Hospitalized Patients with Diverticular Bleeding and Diverticulitis.

Urabe M, Nishida T, Shimakoshi H, Shimoda A, Amano T, Sugimoto A, Takahashi K, Mukai K, Matsubara T, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Tanida T, Komori T, Morita S, Inada M.

Digestion. 2019;99(3):239-246. doi: 10.1159/000491875. Epub 2018 Sep 14.

PMID:
30219818
37.

Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer.

Tamura M, Monzen H, Matsumoto K, Kubo K, Otsuka M, Inada M, Doi H, Ishikawa K, Nakamatsu K, Sumida I, Mizuno H, Yoon DK, Nishimura Y.

Radiat Oncol. 2018 Aug 31;13(1):163. doi: 10.1186/s13014-018-1114-y.

38.

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C.

Tahata Y, Sakamori R, Urabe A, Morishita N, Yamada R, Yakushijin T, Hiramatsu N, Doi Y, Kaneko A, Hagiwara H, Yamada Y, Hijioka T, Inada M, Tamura S, Imai Y, Furuta K, Kodama T, Hikita H, Tatsumi T, Takehara T.

Hepatol Commun. 2018 Aug 6;2(8):884-892. doi: 10.1002/hep4.1206. eCollection 2018 Aug.

39.

Low Molecular-Weight Curdlan, (1→3)-β-Glucan Suppresses TLR2-Induced RANKL-Dependent Bone Resorption.

Aizawa M, Watanabe K, Tominari T, Matsumoto C, Hirata M, Grundler FMW, Inada M, Miyaura C.

Biol Pharm Bull. 2018;41(8):1282-1285. doi: 10.1248/bpb.b18-00057.

40.

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI.

Int J Clin Oncol. 2018 Dec;23(6):1121-1126. doi: 10.1007/s10147-018-1316-1. Epub 2018 Jul 10.

PMID:
29992389
41.

Number of polyps detected is a useful indicator of quality of clinical colonoscopy.

Amano T, Nishida T, Shimakoshi H, Shimoda A, Osugi N, Sugimoto A, Takahashi K, Mukai K, Nakamatsu D, Matsubara T, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M.

Endosc Int Open. 2018 Jul;6(7):E878-E884. doi: 10.1055/a-0605-3264. Epub 2018 Jul 4.

42.

Characterization of xanthine dehydrogenase and aldehyde oxidase of Marsupenaeus japonicus and their response to microbial pathogen.

Okamura Y, Inada M, Elshopakey GE, Itami T.

Mol Biol Rep. 2018 Aug;45(4):419-432. doi: 10.1007/s11033-018-4177-9. Epub 2018 May 16.

PMID:
29767342
43.

A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy.

Inada M, Monzen H, Matsumoto K, Tamura M, Minami T, Nakamatsu K, Nishimura Y.

J Radiat Res. 2018 May 1;59(3):333-337. doi: 10.1093/jrr/rry030.

44.

Stabilization Mechanism of the Tetragonal Structure in a Hydrothermally Synthesized BaTiO3 Nanocrystal.

Hongo K, Kurata S, Jomphoak A, Inada M, Hayashi K, Maezono R.

Inorg Chem. 2018 May 7;57(9):5413-5419. doi: 10.1021/acs.inorgchem.8b00381. Epub 2018 Apr 16.

45.

In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system.

El-Far AHAM, Munesue S, Harashima A, Sato A, Shindo M, Nakajima S, Inada M, Tanaka M, Takeuchi A, Tsuchiya H, Yamamoto H, Shaheen HME, El-Sayed YS, Kawano S, Tanuma SI, Yamamoto Y.

Oncol Lett. 2018 Apr;15(4):4627-4634. doi: 10.3892/ol.2018.7902. Epub 2018 Jan 29.

46.

Tumor Hypoxia Detected by 18F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).

Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M.

Anticancer Res. 2018 Mar;38(3):1775-1781.

PMID:
29491116
47.

Collagenous gastritis: a rare disease with distinctive endoscopic findings.

Hayashi S, Nishida T, Adachi S, Mima A, Inada M.

Gastrointest Endosc. 2018 Jul;88(1):186-187. doi: 10.1016/j.gie.2018.02.013. Epub 2018 Feb 21. No abstract available.

PMID:
29476843
48.

Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma.

Matsubara T, Nishida T, Higaki Y, Tomita R, Shimakoshi H, Shimoda A, Osugi N, Sugimoto A, Takahashi K, Nakamatsu D, Mukai K, Yamamoto M, Fukui K, Adachi S, Inada M.

Intern Med. 2018 Jun 15;57(12):1789-1792. doi: 10.2169/internalmedicine.9851-17. Epub 2018 Feb 9.

49.

Clinically diagnosed late-onset fulminant Wilson's disease without cirrhosis: A case report.

Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M.

World J Gastroenterol. 2018 Jan 14;24(2):290-296. doi: 10.3748/wjg.v24.i2.290.

50.

Effects of Polymethoxyflavonoids on Bone Loss Induced by Estrogen Deficiency and by LPS-Dependent Inflammation in Mice.

Matsumoto S, Tominari T, Matsumoto C, Yoshinouchi S, Ichimaru R, Watanabe K, Hirata M, Grundler FMW, Miyaura C, Inada M.

Pharmaceuticals (Basel). 2018 Jan 20;11(1). pii: E7. doi: 10.3390/ph11010007.

Supplemental Content

Support Center